JP2010534669A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010534669A5 JP2010534669A5 JP2010518340A JP2010518340A JP2010534669A5 JP 2010534669 A5 JP2010534669 A5 JP 2010534669A5 JP 2010518340 A JP2010518340 A JP 2010518340A JP 2010518340 A JP2010518340 A JP 2010518340A JP 2010534669 A5 JP2010534669 A5 JP 2010534669A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- aryl
- cycloalkyl
- arylalkyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 221
- 125000000217 alkyl group Chemical group 0.000 claims 167
- 125000003118 aryl group Chemical group 0.000 claims 135
- 125000000753 cycloalkyl group Chemical group 0.000 claims 128
- 125000003710 aryl alkyl group Chemical group 0.000 claims 124
- 125000001072 heteroaryl group Chemical group 0.000 claims 121
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 110
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 95
- 125000003342 alkenyl group Chemical group 0.000 claims 81
- 229910052739 hydrogen Inorganic materials 0.000 claims 77
- 239000001257 hydrogen Substances 0.000 claims 77
- 125000000304 alkynyl group Chemical group 0.000 claims 76
- 125000004093 cyano group Chemical group *C#N 0.000 claims 68
- 150000002431 hydrogen Chemical class 0.000 claims 64
- 125000005843 halogen group Chemical group 0.000 claims 62
- 125000000623 heterocyclic group Chemical group 0.000 claims 58
- 125000001188 haloalkyl group Chemical group 0.000 claims 56
- 125000004104 aryloxy group Chemical group 0.000 claims 52
- 125000004432 carbon atom Chemical group C* 0.000 claims 50
- 125000004415 heterocyclylalkyl group Chemical group 0.000 claims 50
- 125000005842 heteroatom Chemical group 0.000 claims 47
- 229910052799 carbon Inorganic materials 0.000 claims 43
- 229910052760 oxygen Inorganic materials 0.000 claims 40
- 229910052717 sulfur Inorganic materials 0.000 claims 35
- 101100516563 Caenorhabditis elegans nhr-6 gene Proteins 0.000 claims 18
- 125000001153 fluoro group Chemical group F* 0.000 claims 17
- 150000001875 compounds Chemical class 0.000 claims 16
- 125000005353 silylalkyl group Chemical group 0.000 claims 16
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 11
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- -1 —OH Chemical group 0.000 claims 7
- 241000239366 Euphausiacea Species 0.000 claims 6
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- 206010065040 AIDS dementia complex Diseases 0.000 claims 1
- 206010001889 Alveolitis Diseases 0.000 claims 1
- 206010002329 Aneurysm Diseases 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 102000009410 Chemokine receptor Human genes 0.000 claims 1
- 108050000299 Chemokine receptor Proteins 0.000 claims 1
- 102000019034 Chemokines Human genes 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010037660 Pyrexia Diseases 0.000 claims 1
- 208000030886 Traumatic Brain injury Diseases 0.000 claims 1
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 201000001155 extrinsic allergic alveolitis Diseases 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 208000022098 hypersensitivity pneumonitis Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 230000003589 nefrotoxic effect Effects 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- 231100000381 nephrotoxic Toxicity 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 0 CCC(CN(CC1)C(NN**)=*)[C@@]1(*)c1ccc(C)cc1 Chemical compound CCC(CN(CC1)C(NN**)=*)[C@@]1(*)c1ccc(C)cc1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95147907P | 2007-07-24 | 2007-07-24 | |
| US8152108P | 2008-07-17 | 2008-07-17 | |
| PCT/US2008/070801 WO2009015164A2 (en) | 2007-07-24 | 2008-07-23 | Piperidinyl derivatives as modulators of chemokine receptor activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010534669A JP2010534669A (ja) | 2010-11-11 |
| JP2010534669A5 true JP2010534669A5 (OSRAM) | 2011-08-25 |
Family
ID=40282124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010518340A Withdrawn JP2010534669A (ja) | 2007-07-24 | 2008-07-23 | ケモカイン受容体活性のモジュレーターとしての非環式誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8501782B2 (OSRAM) |
| EP (1) | EP2173713B1 (OSRAM) |
| JP (1) | JP2010534669A (OSRAM) |
| CN (1) | CN101808991A (OSRAM) |
| WO (1) | WO2009015164A2 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7601844B2 (en) * | 2006-01-27 | 2009-10-13 | Bristol-Myers Squibb Company | Piperidinyl derivatives as modulators of chemokine receptor activity |
| TWI433838B (zh) | 2008-06-25 | 2014-04-11 | 必治妥美雅史谷比公司 | 作為趨化因子受體活性調節劑之六氫吡啶衍生物 |
| EP2486034A1 (en) | 2009-10-07 | 2012-08-15 | Bristol-Myers Squibb Company | Spirocyclic compounds as modulators of chemokine receptor activity |
| US8410139B2 (en) | 2009-10-07 | 2013-04-02 | Bristol-Myers Squibb Company | Prodrugs of a piperidinyl derivative as modulators of chemokine receptor activity |
| US8642622B2 (en) | 2010-06-16 | 2014-02-04 | Bristol-Myers Squibb Company | Piperidinyl compound as a modulator of chemokine receptor activity |
| US10011617B2 (en) | 2014-09-26 | 2018-07-03 | The Chemours Company Fc, Llc | Isocyanate derived organosilanes |
| KR102037494B1 (ko) * | 2017-12-11 | 2019-10-28 | 씨제이헬스케어 주식회사 | 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법 |
| GEP20237476B (en) | 2018-09-21 | 2023-03-27 | Pfizer | N-substituted-dioxocyclobutenylamino-3-hydroxypicolinamides useful as ccr6 inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI291467B (en) | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
| FR2862967B1 (fr) * | 2003-12-01 | 2006-08-04 | Sanofi Synthelabo | Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique |
| WO2006004741A2 (en) | 2004-06-28 | 2006-01-12 | Incyte Corporation | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| WO2006137465A1 (ja) * | 2005-06-24 | 2006-12-28 | Shionogi & Co., Ltd. | 含窒素複素環誘導体 |
| US7615556B2 (en) | 2006-01-27 | 2009-11-10 | Bristol-Myers Squibb Company | Piperazinyl derivatives as modulators of chemokine receptor activity |
| US7601844B2 (en) * | 2006-01-27 | 2009-10-13 | Bristol-Myers Squibb Company | Piperidinyl derivatives as modulators of chemokine receptor activity |
-
2008
- 2008-07-23 EP EP08782228.4A patent/EP2173713B1/en not_active Not-in-force
- 2008-07-23 CN CN200880108562A patent/CN101808991A/zh active Pending
- 2008-07-23 US US12/670,016 patent/US8501782B2/en active Active
- 2008-07-23 WO PCT/US2008/070801 patent/WO2009015164A2/en not_active Ceased
- 2008-07-23 JP JP2010518340A patent/JP2010534669A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010534669A5 (OSRAM) | ||
| JP2009524691A5 (OSRAM) | ||
| TW401402B (en) | Novel N-heterocyclyl sulfonamides and pharmaceutical composition and preparation process thereof | |
| ES2925564T3 (es) | Derivados de azetidina tal como moduladores de receptores de quimiocinas y usos de los mismos | |
| KR102093608B1 (ko) | 이미다조피리딘 화합물 | |
| JP2019094345A5 (OSRAM) | ||
| JP2020528889A5 (OSRAM) | ||
| JP2016512515A5 (OSRAM) | ||
| JP2010534670A5 (OSRAM) | ||
| JP2018518537A5 (OSRAM) | ||
| JP2020506951A5 (OSRAM) | ||
| JP2007504160A5 (OSRAM) | ||
| JP2007505138A5 (OSRAM) | ||
| JP2005194283A5 (OSRAM) | ||
| JP2008510828A5 (OSRAM) | ||
| JP2018515531A5 (OSRAM) | ||
| TW200523250A (en) | Compounds for inflammation and immune-related uses | |
| PT1354884E (pt) | Composto de ciclopenta (d) pirazolo [1,5-a] piramida como antagonista de receptor de crf | |
| JP2010539110A5 (OSRAM) | ||
| JP2015508092A5 (OSRAM) | ||
| TW200806652A (en) | N-hydroxyacrylamide compounds | |
| JP2008502670A5 (OSRAM) | ||
| JPS60100585A (ja) | 新規セフエム化合物およびその製造法 | |
| JP2019520344A5 (OSRAM) | ||
| JPWO2023195529A5 (OSRAM) |